CompletedNot Applicable

Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia

234 participantsStarted 2010-11

Plain-language summary

RATIONALE: Studying bone marrow samples from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is studying biomarkers in samples from young patients with acute myeloid leukemia.

Who can participate

Age range21 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

DISEASE CHARACTERISTICS: * Diagnosis of acute myeloid leukemia * Enrolled on CCG-2961 and meeting 1 of the following criteria: * More than 35 days to recover to an ANC \> 500/mm³ after any course of chemotherapy * Consistently recovered \< 35 days to an ANC \> 500/mm³ after all courses of chemotherapy * Available cryopreserved cell from diagnostic and end-of-therapy samples PATIENT CHARACTERISTICS: * Not specified PRIOR CONCURRENT THERAPY: * See Disease Characteristics

What they're measuring

Frequency of mutations

Relapse-free survival

Overall survival

Difference in telomere length

Trial details

NCT IDNCT01247584

SponsorChildren's Oncology Group

Sponsor typeNETWORK

Study typeOBSERVATIONAL

Primary completion2016-05

View on ClinicalTrials.gov More Leukemia trials